The company saw an impressive 56% year-over-year (YOY) boost to revenue, thanks in large part to $12.8 billion in combined sales of its two main GLP-1 agonists, Mounjaro and Zepbound
CrossRef Fecal microbiota transplantation alleviates steatosis and inflammation in high-fat and high-sugar diet-induced fatty liver in mice Fangxia Mi, Jinglu Guo, Wentao Zheng, Jianwei Shen, Hua Ye Frontiers in Cell and Developmental Biology .2026;[Epub] CrossRef Coagulation protease-activated receptor-2 (PAR2) promotes dyslipidemia, obesity and MASLD through repression of the hepatic pioneer factor HNF4 Xinru Chen, Nga Nguyen, Susan E
Before recommending compounded GLP-1 therapy, Dr
doi: 10.1016/j.ygyno.2017.06.027 143 LathamASrinivasanPKemelYShiaJBandlamudiCMandelkerDet al
Furthermore, they may find that their medication has come with unbearable side effects including insomnia, anxiety, and loss of appetite